Home Ingredients Acti-Joint® (Glucosamine, Chondroitin and Hyaluronic Acid — Bioiberica)
Joint Health

Acti-Joint® (Glucosamine, Chondroitin and Hyaluronic Acid — Bioiberica)

Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

Acti-Joint® is a joint-health complex from Bioiberica combining glucosamine, high-purity chondroitin sulfate, and a hyaluronic-acid-rich ingredient (Mobilee). It targets the main structures of the joint, cartilage, synovial fluid, and subchondral bone, with a formula built around the well-studied glucosamine and chondroitin combination.

Studied Dose Around 1500 mg glucosamine and 1200 mg chondroitin per day.
Active Compound Glucosamine plus chondroitin sulfate, combined with a hyaluronic-acid-rich extract.

Benefits

Joint comfort

In a large randomized trial in adults with painful knee osteoarthritis (the MOVES trial), a combined chondroitin sulfate and glucosamine formula reduced joint pain about as much as the anti-inflammatory drug celecoxib. The broader evidence for glucosamine and chondroitin is mixed, however: some large trials (such as GAIT) found no benefit over placebo, and effects tend to appear mainly in more advanced osteoarthritis.

Supported by Trial 1

Cartilage support

Glucosamine and chondroitin supply building blocks of cartilage and are among the raw materials the body uses to maintain cartilage. Whether supplementing them actually slows cartilage breakdown in people is not well established, as most human evidence points to symptom relief rather than structural change.

Supported by Trial 1

Joint lubrication

The hyaluronic-acid-rich component (Mobilee) is included to support the cushioning, lubricating quality of joint fluid, though clinical evidence for oral hyaluronic acid remains limited.

Mechanism of action

1

Cartilage building blocks

Glucosamine and chondroitin provide raw materials for proteoglycans and support the balance between cartilage building and breakdown.

2

Anti-inflammatory and lubrication support

Chondroitin calms joint inflammation while the hyaluronic acid supports the viscosity of synovial fluid.

Clinical trials

1
Glucosamine plus Chondroitin and Knee OA — RCT
PubMed

Multicentre randomized, double-blind, non-inferiority trial of combined chondroitin sulfate and glucosamine versus celecoxib in knee osteoarthritis. (Hochberg et al. 2016, Annals of the Rheumatic Diseases)

Adults with painful knee osteoarthritis.

The glucosamine-chondroitin combination reduced pain comparably to celecoxib, supporting the combination Acti-Joint is built around.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated — digestive symptoms are most common.
Mild stomach upset is occasionally reported.
Glucosamine is derived from shellfish in many products; check the source if allergic.

Important Drug interactions

Warfarin — glucosamine/chondroitin may increase its effect; monitor INR.
Diabetes — monitor blood sugar when starting glucosamine.
Tell your doctor if you have a shellfish allergy.

More Joint Health Ingredients

Joint Health
Curcuwin Ultra+® (144× Bioavailable Curcumin — OmniActive)
Curcuwin Ultra+® is OmniActive's highly bioavailable curcumin — distinguished by 144× grea…
Joint Health
NEM® (Natural Eggshell Membrane — ESM Technologies)
NEM® is the branded standardized natural eggshell membrane developed by ESM Technologies (…
Joint Health
Undenatured Type II Collagen
Undenatured Type II Collagen (sometimes abbreviated UC-2 or native Type II collagen) is a…
Joint Health
Dynagenix® (Water-Soluble Boswellia for Joint + Muscle Recovery — PLT Health)
Dynagenix® is PLT Health Solutions' next-generation water-soluble, neutral-tasting Boswell…

Frequently asked questions about Acti-Joint® (Glucosamine, Chondroitin and Hyaluronic Acid — Bioiberica)

What is Acti-Joint?

Acti-Joint® is a joint-health complex from Bioiberica combining glucosamine, high-purity chondroitin sulfate, and a hyaluronic-acid-rich ingredient (Mobilee). It targets the main structures of the joint, cartilage, synovial fluid, and subchondral bone, with a formula built around the well-studied glucosamine and chondr…

What is Acti-Joint used for?

Acti-Joint is researched primarily for Joint Health. In a large randomized trial in adults with painful knee osteoarthritis (the MOVES trial), a combined chondroitin sulfate and glucosamine formula reduced joint pain about as much as the anti-inflammatory drug celecoxib.

What is the recommended dosage of Acti-Joint?

The clinically studied dose is Around 1500 mg glucosamine and 1200 mg chondroitin per day. Always follow the product label and check with a healthcare provider for personal advice.

Is Acti-Joint safe, and does it have side effects?

For most healthy adults, Acti-Joint is well tolerated at studied doses. Reported effects can include: Generally well-tolerated — digestive symptoms are most common. Mild stomach upset is occasionally reported. It may also interact with some medications. Acti-Joint is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Acti-Joint interact with any medications?

Possible interactions include: Warfarin — glucosamine/chondroitin may increase its effect; monitor INR. Diabetes — monitor blood sugar when starting glucosamine. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Acti-Joint?

NutraSmarts rates the evidence for Acti-Joint as Moderate (3 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Hochberg MC, Martel-Pelletier J, Monfort J, et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016;75(1):37-44..PubMedUsed to support: RCT supporting joint benefit of the glucosamine-chondroitin combination.